Modulari-T
We teach your immune system to attack and cure cancer
Modulari-T operates in advanced therapies based in Montreal, QC, Canada; San Francisco, CA, USA, founded in 2020.
Profile
Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise.
Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue.
Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.
The company sits in the advanced therapies segment, where it competes on its core product or service.
Montreal, QC, Canada; San Francisco, CA, USA is where the company is located.
The company is listed at the Winter 2023 stage of development.
Recorded headcount: 4 employees.
It has disclosed roughly $5K in funding.
| Sector | Advanced Therapies |
|---|---|
| Headquarters | Montreal, QC, Canada; San Francisco, CA, USA |
| Country | USA |
| Founded | 2020 |
| Employees | 4 |
| Stage | Winter 2023 |
| Total funding | $500,000 |
Website: modularit.bio
Create a free account